CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
intermittent fastingbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06299020
NCT06299020N/ACompleted

Risks of Intermittent Fasting in Patients With Primary Adrenal Insufficiency

Hopital La Rabta·interventional·Posted Mar 7, 2024·Updated Feb 14, 2025

In Brief

A clinical study evaluating intermittent fasting for Primary Adrenal Insufficiency and Intermittent Fasting. Completed, enrolled 30 participants across 1 site.

Detailed Summary

In primary adrenal insufficiency, there is an increased risk of hypoglycaemia and dehydration. These risks have been little studied particularly during intermittent fasting. The present study aimed to assess these risks in a prospective study of 30 subjects with primary adrenal insufficiency. Patients will undergo a clinical examination, blood sampling and continuous glucose monitoring for fourteen days (one week of fasting and one week of non-fasting).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesTunisia
Collaborators--

Timeline

N/ACompletedFinished
20252026
First PostedMar 7, 2024
Enrollment StartMar 4, 2024
Primary CompletionApr 20, 2024
Study CompletionDec 1, 2024
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 2.3 years ago

Interventions

intermittent fastingbehavioral

fasting from predawn to sunset (no eating and no drinking), for approximately 16 hours.